PMID- 12444150 OWN - NLM STAT- MEDLINE DCOM- 20021224 LR - 20201219 IS - 0022-1767 (Print) IS - 0022-1767 (Linking) VI - 169 IP - 11 DP - 2002 Dec 1 TI - Function of the lectin domain of Mac-1/complement receptor type 3 (CD11b/CD18) in regulating neutrophil adhesion. PG - 6417-26 AB - A lectin function within CD11b mediates both cytotoxic priming of Mac-1/complement receptor type 3 (CR3) by beta-glucan and the formation of transmembrane signaling complexes with GPI-anchored glycoproteins such as CD16b (FcgammaRIIIb). A requirement for GPI-anchored urokinase plasminogen activator receptor (uPAR; CD87) in neutrophil adhesion and diapedesis has been demonstrated with uPAR-knockout mice. In this study, neutrophil activation conditions generating high-affinity (H-AFN) or low-affinity (L-AFN) beta(2) integrin adhesion were explored. A role for the Mac-1/CR3 lectin domain and uPAR in mediating H-AFN or L-AFN adhesion was suggested by the inhibition of Mac-1/CR3-dependent adhesion to ICAM-1 or fibrinogen by beta-glucan or anti-uPAR. The formation of uPAR complexes with Mac-1/CR3 activated for L-AFN adhesion was demonstrated by fluorescence resonance energy transfer. Conversely, Jurkat cell LFA-1 H-AFN-adhesion to ICAM-1 was not associated with uPAR/LFA-1 complexes, any requirement for GPI-anchored glycoproteins, or inhibition by beta-glucan. A single CD11b lectin site for beta-glucan and uPAR was suggested because the binding of either beta-glucan or uPAR to Mac-1/CR3 selectively masked two CD11b epitopes adjacent to the transmembrane domain. Moreover, treatment with phosphatidylinositol-specific phospholipase C that removed GPI-anchored proteins increased CD11b-specific binding of (125)I-labeled beta-glucan by 3-fold and this was reversed with soluble recombinant uPAR. Conversely, neutrophil activation for generation of Mac-1/CR3/uPAR complexes inhibited CD11b-dependent binding of (125)I-labeled beta-glucan by 75%. These data indicate that the same lectin domain within CD11b regulates both the cytotoxic and adhesion functions of Mac-1/CR3. FAU - Xia, Yu AU - Xia Y AD - Chemoattractant Group of the James Graham Brown Cancer Center, Department of Pathology, University of Louisville, KY 40202, USA. FAU - Borland, Gita AU - Borland G FAU - Huang, Jibiao AU - Huang J FAU - Mizukami, Ikuko F AU - Mizukami IF FAU - Petty, Howard R AU - Petty HR FAU - Todd, Robert F 3rd AU - Todd RF 3rd FAU - Ross, Gordon D AU - Ross GD LA - eng GR - AI27409/AI/NIAID NIH HHS/United States GR - CA42246/CA/NCI NIH HHS/United States GR - CA86412/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Immunol JT - Journal of immunology (Baltimore, Md. : 1950) JID - 2985117R RN - 0 (CD11b Antigen) RN - 0 (CD18 Antigens) RN - 0 (Epitopes) RN - 0 (Glycosylphosphatidylinositols) RN - 0 (Lectins) RN - 0 (Lymphocyte Function-Associated Antigen-1) RN - 0 (Macrophage-1 Antigen) RN - 0 (PLAUR protein, human) RN - 0 (Plaur protein, mouse) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Urokinase Plasminogen Activator) SB - IM MH - Animals MH - Binding Sites MH - CD11b Antigen/*chemistry/metabolism MH - CD18 Antigens/*chemistry/metabolism MH - Cell Adhesion/immunology MH - Epitopes/chemistry MH - Glycosylphosphatidylinositols/metabolism MH - Humans MH - In Vitro Techniques MH - Jurkat Cells MH - Lectins/chemistry/metabolism MH - Lymphocyte Function-Associated Antigen-1/metabolism MH - Macrophage-1 Antigen/*chemistry/metabolism MH - Mice MH - Neutrophils/*cytology/*immunology MH - Protein Structure, Tertiary MH - Receptors, Cell Surface/metabolism MH - Receptors, Urokinase Plasminogen Activator MH - T-Lymphocytes/cytology/immunology EDAT- 2002/11/22 04:00 MHDA- 2002/12/27 04:00 CRDT- 2002/11/22 04:00 PHST- 2002/11/22 04:00 [pubmed] PHST- 2002/12/27 04:00 [medline] PHST- 2002/11/22 04:00 [entrez] AID - 10.4049/jimmunol.169.11.6417 [doi] PST - ppublish SO - J Immunol. 2002 Dec 1;169(11):6417-26. doi: 10.4049/jimmunol.169.11.6417.